Cargando…
Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
BACKGROUND: CSF-soluble platelet-derived growth factor receptor beta (sPDGFRβ) is closely associated with pericyte damage. However, the changes in CSF sPDGFRβ levels and their role in blood–brain barrier (BBB) leakage at different stages of Alzheimer’s disease (AD), with or without cerebral small ve...
Autores principales: | Lv, Xinyi, Zhang, Mengguo, Cheng, Zhaozhao, Wang, Qiong, Wang, Peng, Xie, Qiang, Ni, Ming, Shen, Yong, Tang, Qiqiang, Gao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012584/ https://www.ncbi.nlm.nih.gov/pubmed/36915135 http://dx.doi.org/10.1186/s13195-023-01199-5 |
Ejemplares similares
-
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
por: Wang, Jun, et al.
Publicado: (2022) -
Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes
por: Cicognola, Claudia, et al.
Publicado: (2023) -
Correlation of blood–brain barrier leakage with cerebral small vessel disease including cerebral microbleeds in Alzheimer's disease
por: Cheng, Zhaozhao, et al.
Publicado: (2023) -
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018) -
Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease
por: Lin, Zixuan, et al.
Publicado: (2021)